NEURAXPHARM ARZNEIMITTEL
Neuraxpharm Arzneimittel is a leader in generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). Founded in 1985, the company is a trusted brand for neurologists, psychiatrists, pharmacists and patients. It has a portfolio of 100 predominantly differentiated products to serve the needs of CNS patients.
NEURAXPHARM ARZNEIMITTEL
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
1985-01-01
Address:
Langenfeld, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.neuraxpharm.de
Total Employee:
11+
Status:
Active
Contact:
49 02173 10600
Technology used in webpage:
SPF Content Delivery Network Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Route 53 Amazon Frankfurt Region Symantec.cloud
Similar Organizations
betapharm Arzneimittel GmbH
betapharm Arzneimittel distributes generic pharmaceuticals in the German market.
Neuraxpharm
Neuraxpharm is a Pharmaceutical Company.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-02-01 | Farmax | Farmax acquired by Neuraxpharm Arzneimittel | N/A |
Official Site Inspections
http://www.neuraxpharm.de Semrush global rank: 679.34 K Semrush visits lastest month: 27.55 K
- Host name: ec2-18-197-84-23.eu-central-1.compute.amazonaws.com
- IP address: 18.197.84.23
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Neuraxpharm Arzneimittel"
Home - Neuraxpharm Deutsch
Wir finden Therapieoptionen für Erkrankungen im Zusammenhang mit dem zentralen Nervensystem. Jeder vierte Mensch auf der Welt wird irgendwann in seinem Leben von einer psychischen oder neurologischen Störung betroffen …See details»
Executive Committee - Neuraxpharm
Our Executive Committee consists of experts with broad experience across pharmaceutical and related industries, with the aim to guide the organization into a successful future.See details»
About Neuraxpharm - Neuraxpharm
Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS). We are specialists in this field since 1985 and our more than 35 years’ …See details»
Neuraxpharm - Crunchbase Company Profile & Funding
Neuraxpharm is a Pharmaceutical Company. View contacts for Neuraxpharm to access new leads and connect with decision-makers. Neuraxpharm develops and commercializes branded and …See details»
Neuraxpharm – Wikipedia
Neuraxpharm ist ein europäisches Pharmaunternehmen mit Hauptsitz in Langenfeld und Barcelona sowie weiteren Niederlassungen in Europa. Neuraxpharm ist auf Arzneimittel und andere Medizinprodukte zur Behandlung und Prävention von Erkrankungen des Zentralen Nervensystems (ZNS) spezialisiert. See details»
Neuraxpharm | LinkedIn
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It …See details»
Neuraxpharm - LinkedIn
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It …See details»
Neuraxpharm Arzneimittel - Crunchbase Company Profile & Funding
Neuraxpharm Arzneimittel is a leader in generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). Founded in 1985, the company is a trusted …See details»
Ãœber uns - Neuraxpharm Deutsch
Gegründet wurde die Tochtergesellschaft in Deutschland im Jahr 2016, aufbauend auf dem bereits seit 1985 bestehenden, renommierten Unternehmen neuraxpharm® Arzneimittel …See details»
Neuraxpharm reports another year of sustained growth and …
Nov 14, 2024 · Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, …See details»
Permira funds to acquire leading European CNS specialty …
Permira, the global private equity firm, today announced that a company backed by the Permira funds has agreed to acquire Neuraxpharm, a leading European specialty pharmaceutical …See details»
Neuraxpharm (DE) - life-sciences-europe.com
Aug 1, 2016 · Neuraxpharm (DE) https://www.neuraxpharm.de Created in August 2016, following the acquisition by funds advised by Apax Partners, the Group Invent Farma / neuraxpharm is a …See details»
Home - Neuraxpharm, your CNS Specialist
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders.See details»
Neuraxpharm reports another year of sustained growth and …
Nov 14, 2024 · Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and …See details»
Neuraxpharm - Success Stories | Invest Europe
In Neuraxpharm, the Apax Funds saw the opportunity to create a European champion in central nervous system (CNS) specialty pharmaceuticals, consolidating a fragmented market by …See details»
Neuraxpharm - LinkedIn
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It …See details»
Neuraxpharm Arzneimittel Company Profile - Office Locations ...
Neuraxpharm Arzneimittel is a pharmaceutical generic central nervous system company. It specializes in standard and differentiated generics. The company offers antidepressants, …See details»
Forschung & Entwicklung - Neuraxpharm Deutsch
Neuraxpharm verfügt über 35 Jahre Erfahrung als Spezialist für Erkrankungen des zentralen Nervensystems. Die wissenschaftliche Arbeit unserer F&E-Anstrengungen wird von unserem …See details»
Buprenorphine Neuraxpharm | European Medicines Agency (EMA)
On 17 October 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal …See details»
Ãœber uns - Neuraxpharm AT
Unser Portfolio umfasst über 120 Moleküle, die verschiedene Optionen zur Behandlung von Depression, Angstzuständen, Parkinson, Alzheimer, Epilepsie, Schizophrenie/Psychosen und …See details»